MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 120 filers reported holding MAXCYTE INC in Q3 2023. The put-call ratio across all filers is 10.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $956,776 | -11.8% | 208,448 | -4.9% | 0.00% | -20.0% |
| Q1 2023 | $1,085,317 | +9.9% | 219,256 | +21.3% | 0.01% | 0.0% |
| Q4 2022 | $987,218 | +51.4% | 180,809 | +80.4% | 0.01% | +25.0% |
| Q3 2022 | $652,000 | – | 100,254 | +196476.5% | 0.00% | – |
| Q2 2022 | $0 | – | 51 | +37.8% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 37 | -78.4% | 0.00% | – |
| Q3 2021 | $2,000 | – | 171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
| Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
| Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
| Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
| RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
| Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
| Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
| Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
| First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
| Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |